These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Leptin-induced Notch and IL-1 signaling crosstalk in endometrial adenocarcinoma is associated with invasiveness and chemoresistance. Daley-Brown D; Harbuzariu A; Kurian AA; Oprea-Ilies G; Gonzalez-Perez RR World J Clin Oncol; 2019 Jun; 10(6):222-233. PubMed ID: 31367531 [TBL] [Abstract][Full Text] [Related]
4. Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer. Rene Gonzalez R; Watters A; Xu Y; Singh UP; Mann DR; Rueda BR; Penichet ML Breast Cancer Res; 2009; 11(3):R36. PubMed ID: 19531256 [TBL] [Abstract][Full Text] [Related]
5. Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status. Ray A; Nkhata KJ; Cleary MP Int J Oncol; 2007 Jun; 30(6):1499-509. PubMed ID: 17487372 [TBL] [Abstract][Full Text] [Related]
6. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway. Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829 [TBL] [Abstract][Full Text] [Related]
7. Combination Treatment with EGFR Inhibitor and Doxorubicin Synergistically Inhibits Proliferation of MCF-7 Cells and MDA-MB-231 Triple-Negative Breast Cancer Cells In Vitro. Abrahams B; Gerber A; Hiss DC Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474312 [TBL] [Abstract][Full Text] [Related]
8. Iron oxide nanoparticles induce ferroptosis via the autophagic pathway by synergistic bundling with paclitaxel. Nie Q; Chen W; Zhang T; Ye S; Ren Z; Zhang P; Wen J Mol Med Rep; 2023 Oct; 28(4):. PubMed ID: 37681444 [TBL] [Abstract][Full Text] [Related]
9. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite. Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004 [TBL] [Abstract][Full Text] [Related]
10. Obesity induced a leptin-Notch signaling axis in breast cancer. Battle M; Gillespie C; Quarshie A; Lanier V; Harmon T; Wilson K; Torroella-Kouri M; Gonzalez-Perez RR Int J Cancer; 2014 Apr; 134(7):1605-16. PubMed ID: 24114531 [TBL] [Abstract][Full Text] [Related]
11. Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer. Zhou DD; Bai WQ; Zhai XT; Sun LP; Zhen YS; Li ZR; Miao QF Mil Med Res; 2021 Dec; 8(1):63. PubMed ID: 34879870 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiol. Girgert R; Emons G; Gründker C BMC Cancer; 2014 Dec; 14():935. PubMed ID: 25496649 [TBL] [Abstract][Full Text] [Related]
13. Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2). Gonzalez RR; Cherfils S; Escobar M; Yoo JH; Carino C; Styer AK; Sullivan BT; Sakamoto H; Olawaiye A; Serikawa T; Lynch MP; Rueda BR J Biol Chem; 2006 Sep; 281(36):26320-8. PubMed ID: 16825198 [TBL] [Abstract][Full Text] [Related]
15. Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway. Haque I; Ghosh A; Acup S; Banerjee S; Dhar K; Ray A; Sarkar S; Kambhampati S; Banerjee SK BMC Cancer; 2018 Jan; 18(1):99. PubMed ID: 29370782 [TBL] [Abstract][Full Text] [Related]
16. Elevated estrogen receptor β expression in triple negative breast cancer cells is associated with sensitivity to doxorubicin by inhibiting the PI3K/AKT/mTOR signaling pathway. Lei S; Fan P; Wang M; Zhang C; Jiang Y; Huang S; Fang M; He Z; Wu A Exp Ther Med; 2020 Aug; 20(2):1630-1636. PubMed ID: 32742395 [TBL] [Abstract][Full Text] [Related]
17. Leptin Signaling Affects Survival and Chemoresistance of Estrogen Receptor Negative Breast Cancer. Lipsey CC; Harbuzariu A; Robey RW; Huff LM; Gottesman MM; Gonzalez-Perez RR Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471192 [TBL] [Abstract][Full Text] [Related]
19. Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer. Larsson P; Pettersson D; Olsson M; Sarathchandra S; Abramsson A; Zetterberg H; Ittner E; Forssell-Aronsson E; Kovács A; Karlsson P; Helou K; Parris TZ Cell Death Discov; 2024 Jan; 10(1):57. PubMed ID: 38286854 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of growth hormone receptor by Somavert reduces expression of GPER and prevents growth stimulation of triple-negative breast cancer by 17β-estradiol. Girgert R; Emons G; Gründker C Oncol Lett; 2018 Jun; 15(6):9559-9566. PubMed ID: 29805678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]